FDA Clearance Tracker · P040048-S015
TRILOGY AB ACETABULAR SYSTEM
Last checked: Nov 20, 2026Latest source record: Nov 4, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Nov 4, 2011
Approved
Time to decision
143 days
Received Jun 14, 2011. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P040048-S015
- Device name
- TRILOGY AB ACETABULAR SYSTEM
- Applicant
- Zimmer, Inc.
- Applicant location
- Warsaw, IN
- Received
- Jun 14, 2011
- Decided
- Nov 4, 2011
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P040048
Device type
- Device type
- Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented (MRA)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.
Source documents
Other decisions for Zimmer, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262955 · Decided Sep 24, 2026 · 31 days after receipt
Device type: Prosthesis, Total Anatomic Shoulder, Uncemented Metaphyseal Humeral Stem With No Diaphyseal Incursion, Semi-Constrained (PKC) · Orthopedic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.